Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-05-16 5:27 pm Unchanged | 13D | CAZOO GROUP LTD CZOO | VIKING GLOBAL INVESTORS LP | 3,000,000 7.2% | 0 (Unchanged) | View |
2023-04-27 4:30 pm Unchanged | 13D | CAZOO GROUP LTD CZOO | VIKING GLOBAL INVESTORS LP | 3,000,000 7.2% | 0 (Unchanged) | View |
2023-03-21 4:46 pm Unchanged | 13D | CAZOO GROUP LTD CZOO | VIKING GLOBAL INVESTORS LP | 3,000,000 7.2% | 0 (Unchanged) | View |
2023-02-27 5:10 pm Purchase | 13D | CAZOO GROUP LTD CZOO | VIKING GLOBAL INVESTORS LP | 3,000,000 7.2% | 3,000,000 (New Position) | View |
2023-02-14 1:18 pm Purchase | 13G | PHARVARIS N V REGISTERED PHVS | VIKING GLOBAL INVESTORS LP | 3,231,923 9.7% | 776,387 (+31.62%) | View |
2023-02-14 1:18 pm Sale | 13G | GUARDANT HEALTH INC GH | VIKING GLOBAL INVESTORS LP | 4,107,644 4% | -1,014,851 (-19.81%) | View |
2023-02-14 1:18 pm Sale | 13G | AMYLYX PHARMACEUTICALS INC AMLX | VIKING GLOBAL INVESTORS LP | 4,634,606 7% | -1,135,930 (-19.68%) | View |
2023-02-14 1:18 pm Purchase | 13G | TREVI THERAPEUTICS INC TRVI | VIKING GLOBAL INVESTORS LP | 6,162,362 9.99% | 177,628 (+2.97%) | View |
2023-02-14 1:18 pm Purchase | 13G | INHIBRX INC INBX | VIKING GLOBAL INVESTORS LP | 6,639,199 15.2% | 1,333,333 (+25.13%) | View |
2023-02-14 1:18 pm Sale | 13G | FIGS INC FIGS | VIKING GLOBAL INVESTORS LP | 0 0% | -13,340,414 (Position Closed) | View |
2023-02-14 1:18 pm Purchase | 13G | API GROUP CORP COM APG | VIKING GLOBAL INVESTORS LP | 42,095,793 17.4% | 632,379 (+1.53%) | View |
2023-02-14 1:18 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 8,323,821 9.5% | 220,294 (+2.72%) | View |
2023-02-14 1:18 pm Purchase | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | VIKING GLOBAL INVESTORS LP | 143,085,126 9.36% | 28,000,998 (+24.33%) | View |
2023-02-14 1:18 pm Sale | 13G | COUPA SOFTWARE INC COUP | VIKING GLOBAL INVESTORS LP | 0 0% | -4,168,030 (Position Closed) | View |
2023-02-14 1:18 pm Sale | 13G | PEPGEN INC PEPG | VIKING GLOBAL INVESTORS LP | 1,544,631 6.5% | -249,292 (-13.90%) | View |
2023-02-14 1:18 pm Sale | 13G | CELLDEX THERAPEUTICS INC C CLDX | VIKING GLOBAL INVESTORS LP | 0 0% | -2,366,385 (Position Closed) | View |
2023-02-14 1:18 pm Sale | 13G | PROCEPT BIOROBOTICS CORP COM PRCT | VIKING GLOBAL INVESTORS LP | 0 0% | -3,658,892 (Position Closed) | View |
2023-02-14 1:17 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | VIKING GLOBAL INVESTORS LP | 4,409,146 7% | 1,681,897 (+61.67%) | View |
2023-02-14 1:17 pm Sale | 13G | ORION ACQUISITION CORP OHPA | VIKING GLOBAL INVESTORS LP | 0 0% | -3,669,272 (Position Closed) | View |
2022-11-25 1:43 pm Sale | 13D | FRAZIER LIFESCIENCES ACQ CORP FLAC | VIKING GLOBAL INVESTORS LP | 0 0% | -3,671,462 (Position Closed) | View |